Orthopedic Soft Tissue Repair Market Size, Industry Share, Forecast, 2032

Orthopedic Soft Tissue Repair Market Size

[ 170 + Pages Research Report ] to surpass USD 19.6 billion by 2032 from USD 10 billion in 2021 at a CAGR of 6.3% in the coming years, i.e., 2022-32.

Orthopedic soft tissues are the cells that join the muscles, ligaments, fascia, cartilage, skin, and fibrous tissues. Orthopedic soft tissue repair devices can help treat tissue damage. The wear and tear caused by degeneration of these tissues can be treated with orthopedic soft tissue repair devices. Reparative and Restorative approaches have been discovered to treat these disorders. Orthopedic soft tissue repairs are performed with fully minimally invasive techniques like arthroscopy or open surgical techniques. The most common soft tissue injuries include strains, bursitis, contusions, sprains, tendinitis, and stress injuries. These kinds of accidents might happen due to falls or monotonous use, and they often occur in sports-related accidents.

Market Highlights

The Orthopedic Soft Tissue Repair Market is expected to project a notable CAGR of 6.3% in 2032.

The orthopedic soft tissue repair market is anticipated to progress further as a result of rising demand for less invasive surgeries, rising healthcare costs, and a lack of alternatives for procedures. Moreover, it is predicted that the increase in soft tissue injuries may again boost the growth of the orthopedic soft tissue repair market.

Orthopedic Soft Tissue Repair Market: Segments

The Cruciate Ligaments Repair segment is expected to grow with a higher CAGR during 2022-32

The Orthopedic Soft Tissue Repair market is categorized on the basis of Application into Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapse, Gluteal Tendon Repair, Cruciate Ligaments Repair, Hip Arthroscopy, Biceps Tenodesis, and Others. The cruciate ligaments repair segment witnessed maximum growth in 2020 and is expected to progress further and contribute majorly to the orthopedic soft tissue repair market. The growth of the segment is attributed to the growing number of ACL injuries across the globe. Athletes are reporting more number of sports injuries due to the proliferation of sports activities, which is fueling the need for better orthopedic soft tissue healing solutions.

The Knee segment is expected to grow with a higher CAGR during 2022-32

The Orthopedic Soft Tissue Repair market is categorized on the basis of Injury Location into Knee, Shoulder, Hip, and Small Joints. The knee segment led the orthopedic soft tissue repair market in 2020, and this trend is projected to continue in the coming years as well. This growth is credited to the adoption of a growing number of treatment choices in the developing and developed nations, and also growing applications and acceptability of orthopedic soft tissue repair surgeries. The acceptance and cost of various treatment alternatives are also anticipated to contribute to the growth of the market.

Market Dynamics

Drivers

The Growing Incidences of Soft Tissue Injuries and Technological Advancements

The orthopedic soft tissue repair market is expected to progress due to the growing cases of soft tissue injuries. The orthopedic connective tissue repair domain continues to experience technological advancements and discoveries. In order to improve the efficacy of these treatments, new developments, such as inventive surgical methods, are also marked in the field of Anterior Cruciate Ligament (ACL) reconstruction. In the near future, such breakthroughs, improvements, and advancements would fuel market development. Also, it is predicted that rising traffic accidents will significantly boost market demand.

Increasing Awareness for the Growth, Commercialization, and Promotion of Advanced PRP Devices

The growing awareness among population that individuals with skeletally immature bones could also break their ligaments and connective tissue have helped the market expand. Long-term market growth is also predicted to be supported by growing public awareness regarding the development, marketing, and commercialization of improved platelet-rich plasma devices. As a result, this component will act crucially in boosting the market in the near future.

Restraint

High Costs of Orthopedic Surgeries

The significantly priced orthopedic surgical procedures and a lack of knowledge on cutting-edge therapies are anticipated to restrain market expansion. The most commonly operated high-priced surgeries include percutaneous coronary angioplasty, knee replacement, and spinal fusion. The orthopedic soft tissue repair market is anticipated to face challenges due to limited or absent reimbursement policies over the forecast period.

Recent Developments

Smith & Nephew, in January 2021, purchased the Extremity Orthopedics division from Integra LifeSciences Holdings Corporation for nearly USD 240 million. The acquisition is aimed at the growth of the extremities segment, and also shoulder replacement and foot and ankle categories.
Panther Orthopedics lately declared the use of the PUMA system. It is indicated for hallux valgus reconstruction, syndesmosis fixation, and tarsometatarsal fixation. The soft tissue platform technology of the system is used in lapidus surgeries.

Orthopedic Soft Tissue Repair Market: Key Players

Smith & Nephew Plc
Integra LifeSciences
Panther Orthopedics
Arthrex
DePuy Synthes Companies
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Company
CONMED Corporation
AlloSource
LifeNet Health
Covidien
Lifecell Corporation
Surgalign Holdings
American Medical Systems Inc.
Other Prominent Players

Orthopedic Soft Tissue Repair Market: Regions

The Orthopedic Soft Tissue Repair market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominates the major share of the orthopedic soft tissue repair industry owing to rising healthcare costs. Moreover, the presence of a sizable prospective geriatric population is expected to support the growth of the orthopedic soft tissue repair market in the region throughout the course of the projection period.

Impact of Covid-19 on Orthopedic Soft Tissue Repair Market

The healthcare facilities were forced to reschedule and prioritize treatments as crucial or non-crucial due to factors like lack of Personal Protective Equipment (PPE), trained crew, several restrictions, and lockdown. Due to the enormous market, a number of orthopedic procedures were thought to be necessary during this pandemic. The pandemic had an impact on significant firms' operations, supply chains, product distribution, manufacturing, and other commercial activities. A reduction in sales of orthopedic soft tissue repair products has been reported by numerous industry players.

Orthopedic Soft Tissue Repair Market is further segmented by region into:

North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Orthopedic Soft Tissue Repair Market report also contains analysis on:

Orthopedic Soft Tissue Repair Market Segments:

By Application
- Rotator Cuff Repair
- Epicondylitis
- Achilles Tendinosis Repair
- Pelvic Organ Prolapse
- Gluteal Tendon Repair
- Cruciate Ligaments Repair
- Hip Arthroscopy
- Biceps Tenodesis
- Others
By Injury Location
- Knee
- Shoulder
- Hip
- Small Joints
Orthopedic Soft Tissue Repair Dynamics
Orthopedic Soft Tissue Repair Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Orthopedic Soft Tissue Repair Market Report Scope and Segmentation

Report Attribute	Details
Market size value in 2021	USD 10 Billion
Revenue forecast in 2032	USD 19.6 Billion
Growth Rate	CAGR of 6.3% from 2022 to 2032
Base year for estimation	2021
Quantitative units	Revenue in USD million and CAGR from 2022 to 2032
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Application, Injury Location, and Region
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled	Smith & Nephew Plc, Integra LifeSciences, Panther Orthopedics, Arthrex, DePuy Synthes Companies, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet Company, CONMED Corporation, AlloSource, LifeNet Health, Covidien, Lifecell Corporation, Surgalign Holdings, American Medical Systems Inc., and Other Prominent Players.

Frequently Asked Questions (FAQ):

The Orthopedic Soft Tissue Repair Market was valued at USD 10 billion in 2021 and is expected to reach USD 19.6 billion by 2032, growing at a CAGR of 6.3% from 2022 to 2032.

Orthopedic soft tissue repair devices are used to treat injuries and degeneration of tissues such as ligaments, muscles, cartilage, and tendons. They help in reparative and restorative treatments using minimally invasive or open surgical techniques.

Key applications include Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapse, Gluteal Tendon Repair, Cruciate Ligaments Repair, Hip Arthroscopy, and Biceps Tenodesis. Cruciate Ligaments Repair is witnessing significant growth due to rising ACL injuries.

The market is segmented by injury location into Knee, Shoulder, Hip, and Small Joints. The knee segment leads the market due to increasing adoption of orthopedic soft tissue repair surgeries globally.

Market growth is driven by rising incidences of soft tissue injuries, technological advancements in surgical procedures, increased awareness and commercialization of platelet-rich plasma (PRP) devices, and demand for minimally invasive surgeries.